Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
51,831 articles
Is BrightSpring BTSG Stock Expensive at 24.5x Forward P/E?
BTSG trades at 24.5x forward earnings after strong 2025 results, but 2026 hinges on margin gains offsetting policy-driven revenue headwinds.
BTSG and the Shift to Home Care as Margins Expand in 2026
BTSG targets margin expansion in 2026 as home-care demand grows, but policy and pricing pressures could cloud revenue trends.
Cipher Shares Are Gaining Today - Here's Why
Cipher Digital Inc (NASDAQ:CIFR) shares are rising on Wednesday after announcing a 15-year data center campus lease.
The company also secured a...
Cipher Shares Are Gaining Today - Here's Why
Cipher Digital Inc (NASDAQ:CIFR) shares are rising on Wednesday after announcing a 15-year data center campus lease.
The company also secured a...
Cipher Shares Are Gaining Today - Here's Why
Cipher Digital Inc (NASDAQ:CIFR) shares are rising on Wednesday after announcing a 15-year data center campus lease.
The company also secured a...
Cipher Shares Are Gaining Today - Here's Why
Cipher Digital Inc (NASDAQ:CIFR) shares are rising on Wednesday after announcing a 15-year data center campus lease.
The company also secured a...
How US Army soldiers in Europe are readying for a possible trench war with Russia
Business Insider got exclusive access to see how the US Army's Germany-based 2nd Cavalry Regiment is training for a possible war with Russia.
BTSG Growth Drivers in 2026 Across Specialty and Providers
BTSG leans on specialty and provider growth in 2026, with margin expansion expected to outpace revenue despite near-term pharmacy headwinds.
Will the Recent Label Expansion of BMY's Opdivo Boost Its IO Franchise?
Bristol Myers Squibb's Opdivo expansions highlight pharma companies' push to grow oncology franchises amid rising competition and pipeline innovation.
BTSG Growth Drivers in 2026 Across Specialty and Providers
BTSG leans on specialty and provider growth in 2026, with margin expansion expected to outpace revenue despite near-term pharmacy headwinds.
Will the Recent Label Expansion of BMY's Opdivo Boost Its IO Franchise?
Bristol Myers Squibb's Opdivo expansions highlight pharma companies' push to grow oncology franchises amid rising competition and pipeline innovation.
Will the Recent Label Expansion of BMY's Opdivo Boost Its IO Franchise?
Bristol Myers Squibb's Opdivo expansions highlight pharma companies' push to grow oncology franchises amid rising competition and pipeline innovation.
📰
DFDS A/S – SUMMARY OF ANNUAL GENERAL MEETING
Today, DFDS A/S held its Annual General Meeting (AGM).
📰
DFDS A/S – FORLØB AF ORDINÆR GENERALFORSAMLING
DFDS A/S afholdt tidligere i dag selskabets ordinære generalforsamling.
BTSG Growth Drivers in 2026 Across Specialty and Providers
BTSG leans on specialty and provider growth in 2026, with margin expansion expected to outpace revenue despite near-term pharmacy headwinds.
Immune response to cancer may cause brain disease
COLD SPRING HARBOR, N.Y., March 25, 2026 /PRNewswire/ -- Consider two seemingly unrelated medical puzzles. First: Every day, our bodies produce...
Paychex Q3 Results: Revenue Soars 20% As Small Businesses Turn To AI, Advisory Services
Paychex, Inc. (NASDAQ:PAYX) reported upbeat fiscal third-quarter results on Wednesday, highlighted by an 20% year-over-year increase...
Paychex Q3 Results: Revenue Soars 20% As Small Businesses Turn To AI, Advisory Services
Paychex, Inc. (NASDAQ:PAYX) reported upbeat fiscal third-quarter results on Wednesday, highlighted by an 20% year-over-year increase...
📰
Is There a Path for Pony AI to Achieve Profitability?
Pony AI (NASDAQ:PONY) reports its fourth-quarter and full-year 2025 results before the U.S. market opens on Thursday, March 26. With the stock down...
📰
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 1.51% on an annualized basis producing an average annual return of 13.85%....
Sony Announces New TV and Soundbars as TCL Deal Looms
Sony Group Corp. introduced a new midrange 4K TV and several home theater audio products, going about business as usual even as it nears a deal to...
📰
All You Need to Know About PG&E (PCG) Rating Upgrade to Buy
PG&E (PCG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the...
📰
CMS Energy (CMS) Upgraded to Buy: What Does It Mean for the Stock?
CMS Energy (CMS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the...
📰
What Makes First Bancorp (FBNC) a New Buy Stock
First Bancorp (FBNC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive...
📰
BCB Bancorp (BCBP) Upgraded to Strong Buy: What Does It Mean for the Stock?
BCB Bancorp (BCBP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong...
📰
All You Need to Know About Magnolia Oil & Gas Corp (MGY) Rating Upgrade to Buy
Magnolia Oil & Gas Corp (MGY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This...
📰
Coherus Oncology (CHRS) Upgraded to Buy: Here's What You Should Know
Coherus Oncology (CHRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might...
📰
RF Industries (RFIL) Upgraded to Buy: Here's What You Should Know
RF Industries (RFIL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
📰
Enbridge (ENB) Upgraded to Buy: Here's What You Should Know
Enbridge (ENB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the...
📰
EQT (EQT) Upgraded to Strong Buy: Here's Why
EQT (EQT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
📰
Jabil (JBL) is a Great Momentum Stock: Should You Buy?
Does Jabil (JBL) have what it takes to be a top stock pick for momentum investors? Let's find out.
📰
What Makes Magnolia Oil & Gas Corp (MGY) a Strong Momentum Stock: Buy Now?
Does Magnolia Oil & Gas Corp (MGY) have what it takes to be a top stock pick for momentum investors? Let's find out.
📰
Equinox Gold (EQX) Upgraded to Strong Buy: Here's Why
Equinox Gold (EQX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might...
📰
EQT Corporation (EQT) is a Great Momentum Stock: Should You Buy?
Does EQT Corporation (EQT) have what it takes to be a top stock pick for momentum investors? Let's find out.
OLLOBOT Prepares August Kickstarter Launch for Enhanced OlloNi Following Strong CES 2026 Debut
LAS VEGAS, March 25, 2026 /PRNewswire/ -- OLLOBOT, a brand focused on fusing advanced technology with emotional companionship, announced that the...
Leeann Chin Donates Nearly 12,000 Pounds of Food to Second Harvest Heartland
MINNEAPOLIS, March 25, 2026 /PRNewswire/ -- Leeann Chin proudly partnered with Second Harvest Heartland food bank to donate nearly 12,000 pounds of...
Leeann Chin Donates Nearly 12,000 Pounds of Food to Second Harvest Heartland
MINNEAPOLIS, March 25, 2026 /PRNewswire/ -- Leeann Chin proudly partnered with Second Harvest Heartland food bank to donate nearly 12,000 pounds of...
📰
Bronstein, Gewirtz & Grossman LLC Urges Coty Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces...
REGN Soars 28.9% in Six Months: Is There More Upside Potential in 2026?
Regeneron's rally reflects biotech momentum as pipeline wins and Dupixent growth offset Eylea erosion amid intensifying competition.
REGN Soars 28.9% in Six Months: Is There More Upside Potential in 2026?
Regeneron's rally reflects biotech momentum as pipeline wins and Dupixent growth offset Eylea erosion amid intensifying competition.
EXPLR Announces 2026 National STEM Champions as America Celebrates 250 Years of Innovation
55 Students Across 47 States and 4 Territories Earn Expense-Paid Trips to Washington, D.C. NEW YORK and WASHINGTON, March 25, 2026 /PRNewswire/ --...
REGN Soars 28.9% in Six Months: Is There More Upside Potential in 2026?
Regeneron's rally reflects biotech momentum as pipeline wins and Dupixent growth offset Eylea erosion amid intensifying competition.
REGN Soars 28.9% in Six Months: Is There More Upside Potential in 2026?
Regeneron's rally reflects biotech momentum as pipeline wins and Dupixent growth offset Eylea erosion amid intensifying competition.